The administration of weekly tirzepatide injections (comprising pooled doses of 5 mg, 10 mg, and 15 mg) significantly lowered the likelihood of developing type 2 diabetes in adults suffering from pre-diabetes and obesity or being overweight, in contrast to placebo, over the span of 176 weeks
Similarly, in individuals with overweight or obesity, the SELECT trial demonstrated a 19% reduction in all-cause death with semaglutide, extending the survival benefit of GLP-1 RAs beyond diabetic populations [8, 23]
Comprehensive, medically-supervised program designed to maximize results while ensuring patient safety
While Retatrutide injections near you aren't available yet, staying informed helps make educated decisions when the time comes to choose your weight loss treatment
Increased energy expenditure: Semaglutide may also help improve the body's ability to burn fat and utilize energy more efficiently, contributing to weight loss